Espacenet and Charlie: Artificial Intelligence at the Service of Technological Innovation
Discover how Charlie leverages Espacenet to give you intelligent access to over 140 million worldwide patents, revolutionizing your technology watch and innovation analysis.
Emerit Science Team
Espacenet is the patent search platform of the European Patent Office (EPO), providing free access to over 140 million patent documents from around the world. This monumental database covers technological innovation from the 19th century to the most recent applications, serving as the memory of global industrial innovation.
Espacenet indexes not only European patents but also international applications via the PCT, as well as American, Japanese, Chinese patents, and those from over 100 other patent offices. Each document contains detailed technical information, legal claims, prior art citations, and data on the legal status of patents.
Despite its invaluable wealth for innovation and R&D, Espacenet remains complex to use for many researchers and engineers. Patent classifications (CPC, IPC), multilingual technical terminology, patent families, and prior art analysis require specialized expertise in intellectual property.
It is precisely in this context that Charlie revolutionizes access to patent data. Our AI assistant understands the complex structure of Espacenet and can interpret your questions in natural language to instantly identify relevant patents for your field, whether involving emerging technologies, specific technical solutions, or competitive landscape analyses.
By connecting Espacenet patent data with PubMed scientific publications, GEO genomic data, and other technical databases, Charlie provides an integrated view of innovation, bridging the gap between fundamental research and patented industrial applications.
Why Charlie Integrates Espacenet
The integration of Espacenet into Charlie represents a major strategic advantage for research and innovation. Espacenet contains real technical data on patented inventions, generated by thousands of companies, laboratories, and inventors worldwide, covering virtually every imaginable technological domain. This diversity offers a unique opportunity to analyze innovation trends and discover new technological opportunities.
Patent data in Espacenet is structured according to international standards (IPC and CPC classifications) and accompanied by detailed metadata on inventors, applicants, priority dates, and legal statuses. This standardization enables Charlie to efficiently analyze and compare patents from different offices, providing a global view of innovation that few researchers can obtain manually.
Furthermore, the free and open access to Espacenet aligns with our commitment to open innovation. By enabling Charlie to leverage this public resource, we democratize access to advanced technological intelligence, traditionally reserved for intellectual property departments and specialized consulting firms. Every researcher and innovator can thus benefit from insights based on 140 million patents.
- Over 140 million patents covering all technologies from the 19th century to the most recent innovations
- Worldwide coverage: European patents, PCT, US, JP, CN, and over 100 other patent offices
- Technical classifications: access to IPC and CPC classifications for precise searching by technological domain
- Patent families: automatic identification of patents covering the same invention across different countries
- Legal status and citations: information on patent validity and technical prior art
"Charlie has revolutionized our technology watch. What used to take days of patent analysis on Espacenet is now resolved in minutes. We can now quickly identify patented technical solutions and innovation opportunities in our field." — Dr. Marc Dubois, R&D Director, Biotech Innovation
How Charlie Analyzes Espacenet Patents
Charlie's intelligent use of Espacenet relies on AI algorithms specialized in intellectual property and technical analysis. When you ask a question about a technology, a process, or an innovation domain, Charlie simultaneously queries Espacenet and other scientific databases to build a comprehensive answer linking patents and fundamental research.
Charlie understands the complex structure of patents (publication numbers, IPC/CPC classifications, claims, technical drawings) and can interpret patent documents in multiple languages to filter information according to your needs: technological domain, applicant, inventor, priority date, legal status, and prior art citations.
By cross-referencing Espacenet patent data with PubMed scientific publications, GEO genomic data, and other technical resources, Charlie helps you understand the innovation continuum from fundamental research to patented applications, identify technological opportunities, and analyze the innovation strategies of players in your sector.
The Revolutionary Benefits of Espacenet Integration
With Charlie, you no longer need to master the technical intricacies of patents to leverage this monumental resource. Ask your questions in your usual technical language, and Charlie automatically translates your needs into queries adapted to Espacenet's structure and patent classifications.
This democratization of patent access enables researchers, engineers, and innovators from all backgrounds to harness the power of Espacenet without requiring extensive training in intellectual property, thereby accelerating technological innovation and research valorization.
By integrating Espacenet with major scientific resources such as PubMed and GEO, Charlie builds an interconnected knowledge ecosystem where each patent is contextualized by the underlying scientific research, revealing the complete innovation journey.
Leverage Espacenet like never before
Discover how Charlie can transform your technology watch and R&D by giving you instant access to Espacenet's 140 million patents, analyzed and contextualized by artificial intelligence.
Try Charlie for freeRelated articles
PubMed and Charlie: How Our AI Revolutionizes Scientific Research
Cross-reference patent data with PubMed scientific literature
What Is a Scientific AI Agent?
Understand how AI agents facilitate access to patents
Claude for Life Sciences vs Charlie: Which AI Agent to Choose?
Comparison of AI solutions with access to European patents